Oppenheimer Asset Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-14,614
| Closed | -$92K | – | 1262 |
|
|
2021
Q3 | $92K | Sell |
14,614
-298
| -2% | -$1.88K | ﹤0.01% | 1180 |
|
|
2021
Q2 | $89K | Sell |
14,912
-163
| -1% | -$973 | ﹤0.01% | 1192 |
|
|
2021
Q1 | $95K | Sell |
15,075
-432
| -3% | -$2.72K | ﹤0.01% | 1145 |
|
|
2020
Q4 | $87K | Sell |
15,507
-253
| -2% | -$1.42K | ﹤0.01% | 1117 |
|
|
2020
Q3 | $92K | Sell |
15,760
-520
| -3% | -$3.04K | ﹤0.01% | 1068 |
|
|
2020
Q2 | $117K | Buy |
16,280
+273
| +2% | +$1.96K | ﹤0.01% | 1039 |
|
|
2020
Q1 | $75K | Sell |
16,007
-288
| -2% | -$1.35K | ﹤0.01% | 1176 |
|
|
2019
Q4 | $131K | Sell |
16,295
-412
| -2% | -$3.31K | ﹤0.01% | 1151 |
|
|
2019
Q3 | $115K | Sell |
16,707
-278
| -2% | -$1.91K | ﹤0.01% | 1157 |
|
|
2019
Q2 | $141K | Sell |
16,985
-2,684
| -14% | -$22.3K | ﹤0.01% | 1140 |
|
|
2019
Q1 | $196K | Sell |
19,669
-6,958
| -26% | -$69.3K | ﹤0.01% | 1044 |
|
|
2018
Q4 | $204K | Buy |
+26,627
| New | +$204K | 0.01% | 1000 |
|